Neurocrine Biosciences
NBIX
#1532
Rank
A$17.71 B
Marketcap
$177.72
Share price
-0.80%
Change (1 day)
-14.82%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of December 2024 : A$4.10 Billion

According to Neurocrine Biosciences 's latest financial reports the company has A$4.10 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$A$4.16 B27.09%
2023-12-31$A$3.27 B30.54%
2022-12-31$A$2.50 B32.42%
2021-12-31$A$1.89 B29.4%
2020-12-31$A$1.46 B61.01%
2019-12-31$A$0.90 B33.3%
2018-12-31$A$0.68 B43.17%
2017-12-31$A$0.47 B9.12%
2016-12-31$A$0.43 B-25.03%
2015-12-31$A$0.58 B128.48%
2014-12-31$A$0.25 B88.91%
2013-12-31$A$0.13 B-9.13%
2012-12-31$A$0.14 B153.51%
2011-12-31$A$58.59 M207.68%
2010-12-31$A$19.04 M332.67%
2009-12-31$A$4.4 M-91.56%
2008-12-31$A$52.12 M-61.61%
2007-12-31$A$0.13 B-65.99%
2006-12-31$A$0.39 B-25.12%
2005-12-31$A$0.53 B4.76%
2004-12-31$A$0.50 B-3.28%
2003-12-31$A$0.52 B32.2%
2002-12-31$A$0.39 B-34.55%
2001-12-31$A$0.60 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$3.19 B-22.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.39 B 299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
-A$10.12 Million-100.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$22.61 B 451.09%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.33 B 29.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$140.24 B 3,317.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.67 B-83.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$57.68 Million-101.41%๐Ÿ‡บ๐Ÿ‡ธ USA